Acquired symmetrical dermal melanocytosis (naevus of Hori) developing after aggravated atopic dermatitis

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 903-908

  Murakami, F ^a   Soma, Yoshinao ^b   Mizoguchi, M ^b  

^a ST MARIANNA UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired symmetrical dermal melanocytosis; Atopic dermatitis; KIT; Melanocyte

Indexed keywords

HISTAMINE; SEX HORMONE; STEM CELL FACTOR;

ACQUIRED SYMMETRICAL DERMAL MELANOCYTOSIS; ADULT; ARTICLE; ASIAN; ATOPIC DERMATITIS; CELL MATURATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ECZEMA; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; JAPAN; MALE; MAST CELL; MELANOCYTOSIS; NEVUS OF HORI; PATHOGENESIS; PIGMENT DISORDER; PRIORITY JOURNAL; SKIN INFLAMMATION; SUN EXPOSURE;

ADULT; DERMATITIS, ATOPIC; FACIAL NEOPLASMS; FEMALE; HAND; HUMANS; MALE; MELANOCYTES; MIDDLE AGED; NEVUS, PIGMENTED; SEX FACTORS; SKIN NEOPLASMS;

EID: 18944385689     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06381.x     Document Type: Article

References (28)

1. Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1984; 10:961-4.
2. Sun C-C, Lü Y-C, Lee EF, Nakagawa H. Naevus fusco-caeruleus zygomaticus. Br J Dermatol 1987; 117:545-53.
3. Hidano A, Kaneko K. Acquired dermal melanocytosis of the face and extremities. Br J Dermatol 1991; 124:96-9.
4. Mizoguchi M, Murakami F, Ito M et al. Clinical, pathological, and etiologic aspects of acquired dermal melanocytosis. Pigment Cell Res 1997; 10:176-83.
5. Murakami, F, Baba T, Mizoguchi M. Ultraviolet-induced generalized acquired dermal melanocytosis with numerous melanophages. Br J Dermatol 2000; 142:184-6.
6. Stanford DG, Georgouras KE. Dermal melanocytosis: a clinical spectrum. Australas J Dermatol 1996; 37:19-25.
7. Manuskiatti W, Sivayathorn A, Leelaudomlipi P, Fitzpatrick RE. Treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol 2003; 48:584-91.
8. Hori Y. Reply. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1985; 12:369 (letter).
9. Jimenez E, Valle P, Villegas C et al. Unusual acquired dermal melanocytosis. J Am Acad Dermatol 1994; 30:277-8.
10. Kuniyuki S. Acquired dermal melanocytosis on the wrist. J Dermatol 1997; 24:120-4.
11. Rubin AI, van Laborde S, Stiller MJ. Acquired dermal melanocytosis: appearance during pregnancy. J Am Acad Dermatol 2001; 45:609-13.
12. Fitzpatrick TB, Ortonne J-P. Nevus of Ito. In: Fitzpatrick's Dermatology in General Medicine: Normal Skin Color and General Consideration of Pigmentary Disorders (Freedberg IM, Eisen AZ, WolfF K, Austen KF, Goldsmith LA, Katz SI, eds), 6th edn, Vol. 1. New York: McGraw-Hill, 2003; 873.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92 (Suppl.):44-7.
14. Obara W, Kawa Y, Ra C et al. T cells and mast cells as a major source of interleukin-13 in atopic dermatitis. Dermatology 2002; 205:11-17.
15. Bleehen SS. Post-inflammatory hypermelanosis. In: Textbook of Dermatology: Disorders of Skin Colour (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn, Vol. 2. Oxford: Blackwell Scientific Publications, 1998; 1786.
16. Spielvogel RL, Kantor GR. Postinflammatory pigmentary alteration. In: Lever's Histopathology of the Skin: Pigmentary Disorders of the Skin (Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds), 8th edn. Philadelphia: Lippincott-Raven, 1997; 618.
17. Mizushima K, Nogita T, Higaki Y et al. Dormant melanocytes in the dermis: do dermal melanocytes of acquired dermal melanocytosis exist from birth? Br J Dermatol 1998; 139:349-50.
18. Murakami F, Kawa Y, Kubota Y et al. Pre-existing immature melanocytes in dermal melanocytosis. Pigment Cell Res 1996; 9:173 (Abstract).
19. Ono T, Egawa K, Kayashima K, Kitoh M. Late onset dermal melanocytosis: an upper back variant. J Dermatol 1991; 18:97-103.
20. Okura M, Maeda H, Nishikawa S, Mizoguchi M. Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol 1995; 105:322-8.
21. Ito M, Kawa Y, Ono H et al. Removal of stem cell factor or addition of monoclonal anti-c-KIT antibody induces apoptosis in murine melanocyte precursors. J Invest Dermatol 1999; 112:796-801.
22. Tomita Y, Maeda K, Tagami H. Histamine stimulates normal human melanocytes in vitro: one of the possible inducers of hyperpigmentation in urticaria pigmentosa. J Dermatol Sci 1993; 6: 146-S4.
23. Yoshida M, Hirotsu S, Nakahara M et al. Histamine is involved in ultraviolet B-induced pigmentation of guinea pig skin. J Invest Dermatol 2002; 118:255-60.
24. Zhang S, Anderson DF, Bradding P et al. Human mast cells express stem cell factor. J Pathol 1998; 186:59-66.
25. Ring J, Senter T, Cornell RC et al. Plasma complement and histamine changes in atopic dermatitis. Br J Dermatol 1979; 100:521-30.
26. Ring J. Plasma histamine concentrations in atopic eczema. Clin Allergy 1983; 13:545-52.
27. 1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. J Dermatol Sci 2003; 33:23-9.
28. Kanbe T, Soma Y, Kawa Y et al. Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity. Br J Dermatol 2001; 144:1148-53.